Patents by Inventor Aleidy Marlene Silva Vite

Aleidy Marlene Silva Vite has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10576079
    Abstract: The present invention is directed to methods of treating tuberculosis by providing a pharmaceutically effective amount of a combination of drug compounds.
    Type: Grant
    Filed: September 14, 2018
    Date of Patent: March 3, 2020
    Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Chih-Ming Ho, Daniel L. Clemens, Bai-Yu Lee Clemens, Marcus Aaron Horwitz, Aleidy Marlene Silva Vite, Theodore Kee, Xianting Ding
  • Publication number: 20190125772
    Abstract: Disclosed are pharmaceutical compositions and methods of treating multiple myeloma by providing a pharmaceutically effective amount of each drug in a combination of drugs.
    Type: Application
    Filed: May 4, 2016
    Publication date: May 2, 2019
    Applicants: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, NATIONAL UNIVERSITY OF SINGAPORE
    Inventors: Dean HO, Chih-Ming HO, Aleidy Marlene Silva VITE, Kangyi ZHANG, Edward Kai-Hua CHOW, Tan Boon TOH, Wee Joo CHNG, Masturah Mohd Abdul RASHID
  • Publication number: 20190121935
    Abstract: An initial phenotypic map is derived for a patient subjected to an initial therapeutic regimen including a first drug, based on values of a therapeutic outcome for the patient and corresponding values of a dose of the first drug administered to the patient. Following a change from the initial therapeutic regimen to an updated therapeutic regimen, an updated value of the therapeutic outcome is received for the patient subjected to the updated therapeutic regimen. The initial phenotypic map is re-calibrated according to the updated value of the therapeutic outcome, and, using the re-calibrated phenotypic map, identification is made of a value of the dose of the first drug to be administered to the patient subjected to the updated therapeutic regimen.
    Type: Application
    Filed: March 17, 2016
    Publication date: April 25, 2019
    Applicant: The Regents of the University of California
    Inventors: Dean HO, Chih-Ming HO, Ali ZARRINPAR, Dong-Keun LEE, Aleidy Marlene Silva VITE, Nakul DATTA
  • Publication number: 20190030026
    Abstract: The present invention is directed to methods of treating tuberculosis by providing a pharmaceutically effective amount of a combination of drug compounds.
    Type: Application
    Filed: September 14, 2018
    Publication date: January 31, 2019
    Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Chih-Ming Ho, Daniel L. Clemens, Bai-Yu Lee Clemens, Marcus Aaron Horwitz, Aleidy Marlene Silva Vite, Theodore Kee, Xianting Ding
  • Patent number: 10080749
    Abstract: The present invention is directed to methods of treating tuberculosis by providing a pharmaceutically effective amount of a combination of drug compounds.
    Type: Grant
    Filed: November 3, 2015
    Date of Patent: September 25, 2018
    Assignee: The Regents of the University of California
    Inventors: Chih-Ming Ho, Daniel L. Clemens, Bai-Yu Lee Clemens, Marcus Aaron Horwitz, Aleidy Marlene Silva Vite, Theodore Kee, Xianting Ding
  • Publication number: 20170333427
    Abstract: The present invention is directed to methods of treating tuberculosis by providing a pharmaceutically effective amount of a combination of drug compounds.
    Type: Application
    Filed: November 3, 2015
    Publication date: November 23, 2017
    Applicants: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, SHANGHAI JIAO TONG UNIVERSITY
    Inventors: Chih-Ming Ho, Daniel L. Clemens, Bai-Yu Lee Clemens, Marcus Aaron Horwitz, Aleidy Marlene Silva Vite, Theodore Kee, Xianting Ding